Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease

Autor: Suzanne L. Baker, Jacob W. Vogel, Andreas Lazaris, Michael Schöll, Averill Cantwell, Joel H. Kramer, Rik Ossenkoppele, William J. Jagust, Keith A. Vossel, Nagehan Ayakta, Bruce L. Miller, Maria Luisa Gorno-Tempini, Brianne M. Bettcher, Samuel N. Lockhart, Miguel Santos, Mustafa Janabi, Daniel R. Schonhaut, Gil D. Rabinovici, James P. O'Neil, Zachary A. Miller
Přispěvatelé: Neurology, Amsterdam Neuroscience - Neurodegeneration
Rok vydání: 2016
Předmět:
0301 basic medicine
Apolipoprotein E
Male
cognition
Pathology
Aging
Disease
Neuropsychological Tests
Neurodegenerative
Alzheimer's Disease
Medical and Health Sciences
0302 clinical medicine
80 and over
2.1 Biological and endogenous factors
tau
Aetiology
Aged
80 and over

screening and diagnosis
Aniline Compounds
medicine.diagnostic_test
Neurodegeneration
Brain
Human brain
Middle Aged
Detection
medicine.anatomical_structure
Positron emission tomography
Neurological
Biomedical Imaging
Female
Alzheimer's disease
Psychology
Alzheimer’s disease
APOE
4.2 Evaluation of markers and technologies
medicine.medical_specialty
Amyloid
tau Proteins
Neuroimaging
03 medical and health sciences
Apolipoproteins E
Alzheimer Disease
Fluorodeoxyglucose F18
Clinical Research
mental disorders
medicine
Acquired Cognitive Impairment
Dementia
Humans
Cognitive Dysfunction
Benzothiazoles
Aged
Neurology & Neurosurgery
Psychology and Cognitive Sciences
Neurosciences
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
medicine.disease
Brain Disorders
Thiazoles
030104 developmental biology
Glucose
AV1451 PET
Positron-Emission Tomography
Case-Control Studies
Neurology (clinical)
Neuroscience
030217 neurology & neurosurgery
Carbolines
Zdroj: Brain : a journal of neurology, vol 139, iss Pt 5
Brain, 139, 1551-1567. Oxford University Press
Ossenkoppele, R, Schonhaut, D R, Schoell, M, Lockhart, S N, Ayakta, N, Baker, S L, O'Neil, J P, Janabi, M, Lazaris, A, Cantwell, A, Vogel, J, Santos, M, Miller, Z A, Bettcher, B M, Vossel, K A, Kramer, J H, Gorno-Tempini, M L, Miller, B L, Jagust, W J & Rabinovici, G D 2016, ' Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease ', Brain, vol. 139, pp. 1551-1567 . https://doi.org/10.1093/brain/aww027
Ossenkoppele, R; Schonhaut, DR; Schöll, M; Lockhart, SN; Ayakta, N; Baker, SL; et al.(2016). Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain, 139(5), 1551-1567. doi: 10.1093/brain/aww027. UC Berkeley: Retrieved from: http://www.escholarship.org/uc/item/99g11755
ISSN: 0006-8950
Popis: SEE SARAZIN ET AL DOI101093/BRAIN/AWW041 FOR A SCIENTIFIC COMMENTARY ON THIS ARTICLE: The advent of the positron emission tomography tracer (18)F-AV1451 provides the unique opportunity to visualize the regional distribution of tau pathology in the living human brain. In this study, we tested the hypothesis that tau pathology is closely linked to symptomatology and patterns of glucose hypometabolism in Alzheimer's disease, in contrast to the more diffuse distribution of amyloid-β pathology. We included 20 patients meeting criteria for probable Alzheimer's disease dementia or mild cognitive impairment due to Alzheimer's disease, presenting with a variety of clinical phenotypes, and 15 amyloid-β-negative cognitively normal individuals, who underwent (18)F-AV1451 (tau), (11)C-PiB (amyloid-β) and (18)F-FDG (glucose metabolism) positron emission tomography, apolipoprotein E (APOE) genotyping and neuropsychological testing. Voxel-wise contrasts against controls (at P < 0.05 family-wise error corrected) showed that (18)F-AV1451 and (18)F-FDG patterns in patients with posterior cortical atrophy ('visual variant of Alzheimer's disease', n = 7) specifically targeted the clinically affected posterior brain regions, while (11)C-PiB bound diffusely throughout the neocortex. Patients with an amnestic-predominant presentation (n = 5) showed highest (18)F-AV1451 retention in medial temporal and lateral temporoparietal regions. Patients with logopenic variant primary progressive aphasia ('language variant of Alzheimer's disease', n = 5) demonstrated asymmetric left greater than right hemisphere (18)F-AV1451 uptake in three of five patients. Across 30 FreeSurfer-defined regions of interest in 16 Alzheimer's disease patients with all three positron emission tomography scans available, there was a strong negative association between (18)F-AV1451 and (18)F-FDG uptake (Pearson's r = -0.49 ± 0.07, P < 0.001) and less pronounced positive associations between (11)C-PiB and (18)F-FDG (Pearson's r = 0.16 ± 0.09, P < 0.001) and (18)F-AV1451 and (11)C-PiB (Pearson's r = 0.18 ± 0.09, P < 0.001). Voxel-wise linear regressions thresholded at P < 0.05 (uncorrected) showed that, across all patients, younger age was associated with greater (18)F-AV1451 uptake in wide regions of the neocortex, while older age was associated with increased (18)F-AV1451 in the medial temporal lobe. APOE ϵ4 carriers showed greater temporal and parietal (18)F-AV1451 uptake than non-carriers. Finally, worse performance on domain-specific neuropsychological tests was associated with greater (18)F-AV1451 uptake in key regions implicated in memory (medial temporal lobes), visuospatial function (occipital, right temporoparietal cortex) and language (left > right temporoparietal cortex). In conclusion, tau imaging-contrary to amyloid-β imaging-shows a strong regional association with clinical and anatomical heterogeneity in Alzheimer's disease. Although preliminary, these results are consistent with and expand upon findings from post-mortem, animal and cerebrospinal fluid studies, and suggest that the pathological aggregation of tau is closely linked to patterns of neurodegeneration and clinical manifestations of Alzheimer's disease.
Databáze: OpenAIRE